Orchid Cellmark executes multi-year contract with U.K. Child Maintenance and Enforcement Commission

Orchid Cellmark (Nasdaq:ORCH), a leading worldwide provider of identity DNA testing services, today announced it has executed a multi-year contract with the U.K. Child Maintenance and Enforcement Commission (CMEC), formerly the Child Support Agency (CSA), for the exclusive provision of DNA paternity testing services. Orchid Cellmark delivers its paternity testing services in the U.K. under the Cellmark brand.

Orchid Cellmark believes that the four-year award has the potential to generate approximately £3,500,000 in revenue over such period, with options to extend the contract for a further three years. Orchid Cellmark has been providing DNA paternity testing services to the CSA since 2005 and was re-selected following a competitive process.

"The consistent high quality of our service provision over the last five years is again recognized by the re-award of this contract. Retaining this contract is a reflection of the quality of our people and the service they provide," said Thomas A. Bologna, Orchid Cellmark president and chief executive officer.

Orchid Cellmark has over two decades of experience of DNA paternity testing and provides rapid, accurate and high quality service guided by rigorous quality assurance systems. Accredited by the Ministry of Justice, and to international quality standard ISO17025, Orchid Cellmark's results are accepted as evidence of paternity in U.K. courts. In addition to providing testing to the CSA, the company is a leading provider of confidential DNA paternity testing services to the general public.